VSNOVA applications
Questions that matter.Claims that wait for evidence.
VSNOVA works across two timescales: a respiratory continuity service available today, and future research horizons that must be validated independently before they become products or clinical claims.
Explore the applicationsScientific plausibility opens a question. It does not close the validation gap.
Present and future
Three fields, with their maturity stated plainly.
- 01Current commercial service
Respiratory continuity
How can a clinician-approved plan remain practical and visible between appointments?The programme supports people living with COPD and other chronic respiratory conditions through structured follow-through and responsible review.
BoundaryIt supports established care. Diagnosis, prescribing and treatment remain with the responsible clinician.
- 02Future application horizon
Oncology
How might research follow change during treatment, supportive care, recovery and rehabilitation with greater continuity?VSNOVA is developing biological measurement technology to study meaningful change across a patient journey over time.
BoundaryNo current oncology product or clinical claim. Every use requires purpose-specific evidence, independent validation and regulatory review.
- 03Long-term research
Personalised and longitudinal biohealth
How do relevant biological states vary between people and change over time?Longitudinal research may support more precise questions about adaptation, recovery and health over time.
BoundaryA research direction, not a current diagnostic, monitoring or treatment capability.
Oncology · future R&D
Cancer care changes between the milestones.
Tumour assessment, treatment tolerance, supportive-care needs and recovery can move on different timelines. VSNOVA's oncology horizon asks how biological measurement technology could study meaningful change across that journey over time.
The intended role is to add research context around established care, never to replace imaging, pathology, molecular testing or clinical judgement.
Biology, symptoms and treatment tolerance can change on different timescales. Future research must describe that change without replacing established assessment.
Before any future claim
Every application has to earn specificity.
Each intended use needs a defined purpose, appropriate clinical references, prospective studies, independent validation and the relevant regulatory review. Evidence in one application does not transfer automatically to another.